While some European firms are still reeling from investments in “toxic” paper, concern is mounting about potential losses in more mainstream holdings, as Sarfraz Thind reports
Register for a trial Please sign in to read the full content of this article. If you aren’t already a subscriber, you can register for a free one-month trial.